Altair Nanotechnologies, Inc. today announced it has signed a research agreement with the U.S. Army RDECOM Acquisition Center for a cost reimbursement contract that could be worth up to $1.75 million.
Under the agreement, Altairnano will conduct primary research of sensitive and selective nanosensors in order to determine how single sensing molecules combined with nanoparticles respond to airborne nerve agents and toxic industrial chemicals. Altairnano will also work on incorporating the technology into a portable sensing device that could one day help to protect men and women of the U.S. Army from the threat of chemical weapons.
"This is another important milestone in our work with the military," said Terry M. Copeland, Altairnano's CEO. "We believe Altairnano's technologies are uniquely positioned to help the U.S. Army in the development of portable, life-saving sensors that could one day be utilized on the battlefield. Altairnano is proud to help improve the effectiveness and safety of the men and women defending our nation."